CD55 upregulation in astrocytes by statins as potential therapy for AQP4-IgG seropositive neuromyelitis optica
Human Complement from Innovative Research was used in the following study: CD55 upregulation in astrocytes by statins as potential...
Complement-dependent bystander injury to neurons in AQP4-IgG seropositive neuromyelitis optica
Human Complement from Innovative Research was used in the following study: Complement-dependent bystander injury to neurons in AQP4-IgG seropositive neuromyelitis...
Daratumumab binds to mobilized CD34+ cells of myeloma patients in vitro without cytotoxicity or impaired progenitor cell growth
Human Complement Serum from Innovative Research was used in the following study: Daratumumab binds to mobilized CD34+ cells of...
